GCA
APYX icon

Greenwood Capital Associates’s Apyx Medical APYX Stock Holding History

Greenwood Capital Associates’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,789
Closed -$79.8K – 290
2025
Q4 		$79.8K Hold
22,789
– – 0.01% 255
2025
Q3 		$48.8K Hold
22,789
– – 0.01% 253
2025
Q2 		$51.3K Sell
22,789
-882
-4% -$1.24K 0.01% 248
2025
Q1 		$32.4K Sell
23,671
-208,087
-90% -$287K ﹤0.01% 233
2024
Q4 		$366K Sell
231,758
-26,062
-10% -$36.5K 0.05% 210
2024
Q3 		$320K Sell
257,820
-10,733
-4% -$13.6K 0.04% 212
2024
Q2 		$360K Sell
268,553
-17,409
-6% -$25.7K 0.05% 204
2024
Q1 		$389K Sell
285,962
-6,462
-2% -$13.7K 0.05% 214
2023
Q4 		$766K Sell
292,424
-9,385
-3% -$22.7K 0.1% 156
2023
Q3 		$966K Sell
301,809
-39
-0% -$182 0.14% 135
2023
Q2 		$1.52M Buy
301,848
+16,021
+6% +$81.2K 0.21% 93
2023
Q1 		$823K Sell
285,827
-13,388
-4% -$39.1K 0.12% 147
2022
Q4 		$700K Buy
299,215
+77,909
+35% +$238K 0.11% 146
2022
Q3 		$994K Buy
221,306
+1,437
+0.7% +$10.3K 0.17% 104
2022
Q2 		$1.29M Buy
219,869
+75,576
+52% +$388K 0.21% 89
2022
Q1 		$942K Buy
144,293
+82,244
+133% +$810K 0.25% 83
2021
Q4 		$795K Buy
62,049
+7,194
+13% +$101K 0.11% 156
2021
Q3 		$760K Buy
+54,855
New +$577K 0.12% 142

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Greenwood Capital Associates's APYX Position: Q1 2026 in Review

Greenwood Capital Associates sold out of Apyx Medical (APYX) in Q1 2026, closing a stake of 22,789 shares — an estimated $79.8K sold.

Greenwood Capital Associates first reported a position in APYX in Q3 2021 and held it in 18 quarters. The position peaked at $1.52M in Q2 2023. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Greenwood Capital Associates reported no remaining Apyx Medical position as of Q1 2026 after selling out during the quarter.
  • Greenwood Capital Associates sold 22,789 Apyx Medical shares in Q1 2026, an estimated $79.8K.
  • Greenwood Capital Associates first reported a position in Apyx Medical in Q3 2021 and held it in 18 quarters.
  • Greenwood Capital Associates's Apyx Medical position peaked at $1.52M in Q2 2023.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Greenwood Capital Associates's 13F filing for Q1 2026, filed 29 Apr 2026.